Cancer Treatment
🇺🇸 FDA Page 2FDA news and analysis for pharmaceutical BD, investment, and market access · 9 articles on this page
Unlock global cancer treatment market insights. Stay ahead on drug approvals, clinical trials, and therapeutic advancements for pharma investors & BD.
Showing 13–21 of 21 articles
Phanes Therapeutics to Present Updated Spevatamig Phase 2 Results for Metastatic Pancreatic Cancer at ASCO 2026
AACR 2024: Daily Oncology Research Roundup
ScopeX 2026: Causal AI/ML in Clinical Trials Recap
IceCure Medical ProSense Revenue Surges 30% in Q1 2026 as Cryoablation Technology Gains Traction
FDA Guidance on Oncology Drugs: Impact on Accelerated Approval Pathways
ANVISA Guidelines for Antibody-Drug Conjugates: What You Need to Know
Antibody-Drug Conjugates MEA: Pricing, Access & Adoption Insights 2024
Partner Therapeutics Submits FDA Application for BIZENGRI in Rare Cholangiocarcinoma Cancer Treatment
FDA Approval Mirvetuximab Soravtansine: Accelerated OK for Elahere in Ovarian Cancer